DNA & Genetics Genmab to Acquire Merus for $8B, Expanding Bispecific Antibody Cancer PipelineBy adminSeptember 30, 20250 Genmab has agreed to acquire Merus for approximately $8 billion, the companies said today, in a deal intended to bolster…
Microbiome MRM Health secures $64m for microbiome-based pipelineBy adminSeptember 6, 20250 MH002 is aimed at treating those with mild-to-moderate ulcerative colitis. Credit: Jo Panuwat D/Shutterstock.com. Belgium’s MRM Health has concluded a…
